Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Dual destructive and protective roles of adaptive immunity in neurodegenerative disorders.
Pediatric multiple sclerosis.
Multiple sclerosis and amyotrophic lateral sclerosis: is there a link?
[Chronic inflammatory demyelinating polyradiculoneuropathy(CIDP): Treatment and prognosis].
Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
Feasibility study design and methods for Project GEMS: Guidelines for Exercise in Multiple Sclerosis.
Diffusion Weighted MRI Characterization of White Matter Injury Produced by Axon-sparing Demyelination and Severe Contusion Spinal Cord Injury in Rats.
Patterns Of Use Of Tests To Monitor Disease Activity Among Patients Currently Treated For Relapsing Remitting Multiple Sclerosis (Rrms) In Europe.
What do we know about brain contrast enhancement patterns in neuromyelitis optica?
New insights in the pathophysiology and treatment of multiple sclerosis spasticity and related symptoms. Foreword.
Peloruside A: a lead non-taxoid-site microtubule-stabilizing agent with potential activity against cancer, neurodegeneration, and autoimmune disease.
Sex bias in CNS autoimmune disease mediated by androgen control of autoimmune regulator.
Acute demyelinating lesions with restricted diffusion in multiple sclerosis.
Atypical presentation of Charcot-Marie-Tooth disease 1A: A case report.
CNS myelin structural modification induced in vitro by phospholipases A2.
Neuroprotection of Neuro2a cells and the cytokine suppressive and anti-inflammatory mode of action of resveratrol in activated RAW264.7 macrophages and C8-B4 microglia.
Multi-channel registration of fractional anisotropy and T1-weighted images in the presence of atrophy: application to multiple sclerosis.
Longitudinal change in magnetic susceptibility of new enhanced multiple sclerosis (MS) lesions measured on serial quantitative susceptibility mapping (QSM).
Variations in and predictors of the occurrence of depressive symptoms and mood symptoms in multiple sclerosis: a longitudinal two-year study.
Environmental factors and their interactions with risk genotypes in MS susceptibility.
T-cell responses to distinct AQP4 peptides in patients with neuromyelitis optica (NMO).
Demyelinating diseases in Asia.
Absence of MxA induction is related to a poor clinical response to interferon beta treatment in multiple sclerosis patients.
Researchers Expand Focus on Progressive Forms Of Multiple Sclerosis: Efforts to Pinpoint the Beginning of Disease May Yield Clues to Treatment.
Antimalarial Drug Artemether Inhibits Neuroinflammation in BV2 Microglia Through Nrf2-Dependent Mechanisms.
Pages
« first
‹ previous
…
714
715
716
717
718
719
720
721
722
…
next ›
last »